Health Care: Drugs

Merrimack Pharmaceuticals Inc (MACK: NASDAQ)

$10.43 0.34 | 3.37%
08/27/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 102.76M 47.79M 48.92M 34.22M
Cost of Sales 0.00 0.00 122.19M 96.03M
Gross Operating Profit 102.76M 47.79M -73.27M -61.82M
Selling, General, and Administrative Expenses 30.52M 21.19M 15.80M 14.45M
Research & Development 138.50M 147.14M 0.00 0.00
Operating Income before D & A (EBITDA) -66.26M -120.54M -89.08M -76.27M
Depreciation & Amortization 3.22M 2.59M 3.66M 4.60M
Interest Income 114.00K 166.00K 184.00K 56.00K
Other Income - Net 813.00K 627.00K 1.36M 1.15M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -68.55M -122.34M -91.20M -79.66M
Interest Expense 18.23M 10.94M 553.00K 13.00K
Pre-Tax Income -86.78M -133.27M -91.75M -79.68M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -268.00K 240.00K -477.00K -453.00K
Net Income From Continuing Operations -83.56M -130.68M -91.75M -79.68M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -83.56M -130.68M -91.75M -79.68M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -83.29M -130.92M -91.28M -79.22M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-83.56M -130.68M -91.75M -79.68M
Preferred Dividends
Net Income Available To Common -83.56M -130.68M -91.75M -79.68M
Basic EPS from Continuing Ops. -0.80 -1.32 -1.25 -6.98
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.80 -1.32 -1.25 -6.98
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 -0.03 -0.69
Basic EPS, Total -0.80 -1.32 -1.28 -7.67
Basic Normalized Net Income/Share -0.80 -1.32 -1.25 -6.98
EPS fr Continuing Ops. -0.80 -1.32 -1.25 -6.98
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.80 -1.32 -1.25 -6.98
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 -0.03 -0.69
EPS, Total -0.80 -1.32 -1.28 -7.67
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.80 -1.32 -1.25 -6.98
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with MACK

Latest MACK Headlines from TheStreet

More Financial News for MACK

Press Releases for MACK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter